BMI View: Qatar is in top position among eight countries introducing new technology and practices in
their healthcare systems, according to a study published at the World Innovation Summit for Health
(WISH). Experts assessed the gap between the perceived requirements ..."
BMI View: It is unlikely the Qatari government will respond favourably to the 'discrimination policy'
grievances voiced by the local private healthcare insurance industry this quarter. These were voiced in
response to the government's decision to use one public insura ..."
BMI View: Qatar's public healthcare system will come under greater financial pressure as medicines and healthcare demand rises in line with the country's changing demographic and epidemiological profile. As such, a more balanced distribution of healthcare costs will become increa ..."
BMI View: Despite its favourable risk profile in relation to most of its regional neighbours, we continue to
see Qatar as a relatively modest longer-term commercial proposition for research-based pharmaceutical
manufacturers, on account of its modest population size of less tha ..."
BMI View: Qatar represents a largely risk-free proposition for multinational drug manufacturers, although the potential returns are modest, on the account of a small overall market size. Additionally, despite the authorities' desire to increase the domestic medicine manufacturing ..."
According to recent reports in The Gulf Times, Qatar will have four new drug manufacturers by the end of Q113. The drugmakers will reportedly import their raw materials and produce tablets, syrups and injectables. It is anticipated the drug manufacturers will (in our view eventua ..."